IGC PHARMA, INC. (IGC) Total liabilities 2016–2025
IGC PHARMA, INC. (IGC) total liabilities at each fiscal year-end, per SEC filings.
$2.4MFY2025 · since FY2016: $4.9M → $2.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.4M | -6.4% |
| FY2024 | $2.6M | +13.9% |
| FY2023 | $2.3M | -22.9% |
| FY2022 | $2.9M | -4.0% |
| FY2021 | $3.1M | +25.2% |
| FY2020 | $2.4M | +174.0% |
| FY2019 | $893,000 | -68.0% |
| FY2018 | $2.8M | -29.1% |
| FY2017 | $3.9M | -19.9% |
| FY2016 | $4.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice